NUCB2 and gestational diabetes: The univariate linear regression model revealed that an increase of nesfatin-1 and vaspin serum levels by 1 ng/mL decreased the incidence of GDM by 9.85% and 47.66%, respectively (CI 95%, OR: 0.9015 vs. 0.5234).